Rhenman & Partners Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-220,000
Closed -$13.7M 95
2023
Q4
$13.7M Sell
220,000
-10,000
-4% -$559K 1.37% 27
2023
Q3
$12.9M Hold
230,000
1.39% 28
2023
Q2
$11.6M Sell
230,000
-41,062
-15% -$2.18M 1.22% 32
2023
Q1
$14.7M Buy
271,062
+41,062
+18% +$2.4M 1.62% 23
2022
Q4
$14.4M Buy
230,000
+20,000
+10% +$1.33M 1.5% 28
2022
Q3
$15.4M Sell
210,000
-30,000
-13% -$2.07M 1.61% 25
2022
Q2
$13.6M Hold
240,000
1.55% 23
2022
Q1
$15M Sell
240,000
-75,000
-24% -$4.04M 1.48% 28
2021
Q4
$17.7M Buy
315,000
+25,000
+9% +$1.53M 1.18% 34
2021
Q3
$18.9M Sell
290,000
-90,000
-24% -$6.14M 1.32% 29
2021
Q2
$24.1M Sell
380,000
-30,000
-7% -$1.77M 1.64% 20
2021
Q1
$24.6M Sell
410,000
-50,000
-11% -$2.72M 1.71% 21
2020
Q4
$23M Hold
460,000
1.87% 15
2020
Q3
$23.5M Sell
460,000
-10,000
-2% -$417K 2.09% 15
2020
Q2
$16.5M Buy
470,000
+5,000
+1% +$172K 1.78% 18
2020
Q1
$11.8M Buy
465,000
+135,000
+41% +$4.01M 1.66% 22
2019
Q4
$9.14M Buy
+330,000
New +$7.88M 1% 43

Other funds holding AXNX

Rhenman & Partners Asset Management's AXNX Position: Q1 2024 in Review

Rhenman & Partners Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 220,000 shares — an estimated $13.7M sold.

Rhenman & Partners Asset Management first reported a position in AXNX in Q4 2019 and held it in 17 quarters. The position peaked at $24.6M in Q1 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Rhenman & Partners Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 220,000 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $13.7M.
  • Rhenman & Partners Asset Management first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
  • Rhenman & Partners Asset Management's Axonics, Inc. Common Stock position peaked at $24.6M in Q1 2021.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2024, filed 14 May 2024.